tetano
Editor, Senior Moderator
EXCLI J
. 2022 Jun 30;21:906-920.
doi: 10.17179/excli2022-5073. eCollection 2022.
Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review
Annunziata Stefanile[SUP] 1 [/SUP], Maria Cellerino[SUP] 2 3 [/SUP], Tatiana Koudriavtseva[SUP] 4 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) results in higher risks of hospitalization or death in older patients and those with multiple comorbidities, including malignancies. Patients with cancer have greater risks of COVID-19 onset and worse prognosis. This excess is mainly explained by thrombotic complications. Indeed, an imbalance in the equilibrium between clot formation and bleeding, increased activation of coagulation, and endothelial dysfunction characterize both COVID-19 patients and those with cancer. With this review, we provide a summary of the pathological mechanisms of coagulation and thrombotic manifestations in these patients and discuss the possible therapeutic implications of these phenomena.
Keywords: SARS-CoV-2, COVID-19; cancer; coagulation; thrombotic manifestations.
. 2022 Jun 30;21:906-920.
doi: 10.17179/excli2022-5073. eCollection 2022.
Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review
Annunziata Stefanile[SUP] 1 [/SUP], Maria Cellerino[SUP] 2 3 [/SUP], Tatiana Koudriavtseva[SUP] 4 [/SUP]
Affiliations
- PMID: 36172074
- PMCID: PMC9489888
- DOI: 10.17179/excli2022-5073
Abstract
Coronavirus disease 2019 (COVID-19) results in higher risks of hospitalization or death in older patients and those with multiple comorbidities, including malignancies. Patients with cancer have greater risks of COVID-19 onset and worse prognosis. This excess is mainly explained by thrombotic complications. Indeed, an imbalance in the equilibrium between clot formation and bleeding, increased activation of coagulation, and endothelial dysfunction characterize both COVID-19 patients and those with cancer. With this review, we provide a summary of the pathological mechanisms of coagulation and thrombotic manifestations in these patients and discuss the possible therapeutic implications of these phenomena.
Keywords: SARS-CoV-2, COVID-19; cancer; coagulation; thrombotic manifestations.